AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation

Journal of Cellular Physiology

Volumn 185, Issue 1, 2000, Pages 36-46

  Madireddi, Malavi T ^a   Dent, Paul ^b   Fisher, Paul B ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MEZEREIN; PROTEIN KINASE C ACTIVATOR; RECOMBINANT BETA INTERFERON; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GROWTH SUBSTANCES; HUMANS; INTERLEUKINS; MELANOMA; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0033842787     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V     Document Type: Article

References (43)

1. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
2. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation
3. Cutaneous melanoma
4. The Ras/ Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes
5. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein
6. Tumor progression and the nature of cancer
7. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
8. AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin
9. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells
10. Nuclear assembly
11. Human melanoma: Development and progression
12. Differentiation induction subtraction hybridization (DISH): A strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation
13. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells
14. Use of sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells
15. Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells
16. Regulation of c-fos, c-jun and jun-B gene expression in human melanoma cells induced to terminally differentiate
17. A molecular definition of terminal cell differentiation in human melanoma cells
18. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression
19. The melanoma differentiation associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells
20. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate
21. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth
22. Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference
23. Antitumor promotion and anti-inflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
24. Role of the transcription factor AP-1 in melanoma differentiation
25. Electrophoretic mobility shift assay
26. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma
27. Transcriptional regulation of gene expression during adipocyte differentiation
28. Identification of a novel polypeptide involved in the formation of DNA-containing vesicles during macronuclear development in Tetrahymena
29. Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy
30. Regulation of mda-7 gene expression during human melanoma differentiation
31. Molecular events in melanoma development and progression
32. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6
33. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia
34. Ionizing radiation regulates expression of the c-jun protoonoogene
35. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine
36. Transcriptional switching model for the regulation of tumorigenesis and metastasis by the Ha-ras oncogene: Transcriptional changes in the Ha-ras tumor suppressor gene lysyl oxidase
37. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice
38. CCAAT-enhancer binding protein: A component of a differentiation switch
39. Molecular mechanisms controlling human melanoma progression and metastasis
40. C/EBP alpha regulates generation of C/EBP beta isoforms through activation of specific proteolytic cleavage
41. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction